Aerovate Therapeutics
Incubated by Raven and now Jade Bio (JBIO)

Aerovate was incubated by Raven and is now Jade Biosciences. Jade Biosciences develops autoimmune therapies. Lead candidate JADE101 inhibits APRIL to treat IgAN.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
NewCo
Initial Investment Year
2018